Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012

Eurosurveillance

Volumn 19, Issue 11, 2014, Pages

  Somoskovi, A ^a   Helbling, P ^b   Deggim, V ^a   Homke R ^a   Ritter, C ^a   Bottger E C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CHILD; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTACT EXAMINATION; DISEASE SURVEILLANCE; DNA FINGERPRINTING; GENOTYPE; HUMAN; INCIDENCE; PHYLOGENETIC TREE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; ANTITUBERCULAR AGENTS; CLUSTER ANALYSIS; CONTACT TRACING; DNA FINGERPRINTING; DNA, BACTERIAL; EMIGRANTS AND IMMIGRANTS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SWITZERLAND; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84896445087     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.11.20736     Document Type: Article

References (17)

1. Parsons L, Somoskovi A. Salfinger M. Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci. 2004; 9: 2086-105. http://dx. doi. org/10. 2741/1290.
2. World Health Organization (WHO). Global tuberculosis report 2013. WHO/HTM/TB/2013. 11. Geneva: WHO: 2013. Available from: http://apps. who. int/iris/bitstream/10665/91355/1/9789241564656_eng. pdf.
3. Federal Office of Public Health. La tuberculose en Suisse, 2005-2011. [Tuberculosis in Switzerland, 2005-2011]. Bull OFSP 2013; 21: 343-53. French. Available from: http://www. bag. admin. ch/dokumentation/publikationen/01435/14421/14604/index. html?lang=fr&download=NHzLpZig7t, lnp6I0NTU042l2Z6ln1ae2IZn4Z2qZpnO2Yuq2Z6gpJCLd318fWym162dpYbUzd, Gpd6emK2Oz9aGodetmqaN19XI2IdvoaCUZ, s.
4. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Böttger EC. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol. 2009; 47(6): 1773-80. http://dx. doi. org/10. 1128/JCM. 02501-08.
5. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993; 31(2): 406-9.
6. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006; 44(12): 4498-510. http://dx. doi. org/10. 1128/JCM. 01392-06.
7. Ködmön CS, Niemann S, Lukacs J, Sör E, David S, Somoskovi A. Molecular epidemiology of drug-resistant tuberculosis in Hungary. J Clin Microbiol. 2006; 44(11): 4258-61. http://dx. doi. org/10. 1128/JCM. 01254-06.
8. Niemann S, Rüsch-Gerdes S, Richter E. IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J Clin Microbiol. 1997; 35(12): 3015-20.
9. Diriba B, Berkessa T, Mamo G, Tedla Y, Ameni G. Spoligotyping of multidrug-resistant Mycobacterium tuberculosis isolates in Ethiopia. Int J Tuberc Lung Dis. 2013; 17(2): 246-50. http://dx. doi. org/10. 5588/ijtld. 12. 0195.
10. Bang D, Lillebaek T, Thomsen VØ, Andersen AB. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007. Scand J Infect Dis. 2010; 42(4): 288-93. http://dx. doi. org/10. 3109/00365540903456282.
11. Denholm JT, Leslie DE, Jenkin GA, Darby J, Johnson PD, Graham SM, et al. Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010. Int J Tuberc Lung Dis. 2012; 16(10): 1320-5. http://dx. doi. org/10. 5588/ijtld. 12. 0092.
12. Vázquez-Gallardo R, Anibarro L, Fernández-Villar A, Díaz-Cabanela D, Cruz-Ferro E, Pérez del Molino ML, et al. Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission. Int J Tuberc Lung Dis. 2007; 11(4): 429-35.
13. Kubica T, Rüsch-Gerdes S, Niemann S. The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany. Int J Tuberc Lung Dis. 2004; 8(9): 1107-13.
14. Bottger EC, Springer B, Pletschette M, Sander P. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat Med. 1998 4(12): 1343-4. http://dx. doi. org/10. 1038/3906.
15. Borrell S and Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009; 13(12): 1456-66.
16. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Inf Dis. 2003; 3(1): 13-21. http://dx. doi. org/10. 1016/S1473-3099(03)00483-3.
17. Sandgren A, Sane Schepisi M, Sotgiu G, Huitric E, Migliori GB, Manissero D, et al. Tuberculosis transmission between foreign and native-born in EU/EEA: systematic review. Eur Respir J. 2013 Oct 10. [Epub ahead of print] http://dx. doi. org/10. 1183/09031936. 00117213.